| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC3343 | |||||||||||||||||||||||
| Submitter : | Mrs. Teresa Tillotson | Date & Time: | 12/15/2006 08:12:57 | |||||||||||||||||||||
| Organization : | Mrs. Teresa Tillotson | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| My family and I are completely opposed to the use of aborted fetal cell line products. It is our sincere hope that no medicines or vaccines will be developed using these aborted fetal cell line products. It is always immoral to use another human being without proper consent--which in the case of aborted babies is non-existent.
Sincerely, Teresa Tillotson | ||||||||||||||||||||||||